PRKDC and cancer: Apart from insulin-like growth factor receptor-driven activation of PI3K and Akt mentioned above63,64, activation of other pathways such as DNA-PK or MAPK/ERK or inactivation of GSK3-dependent proteasomal degradation of oncogenic proteins can promote cancer cell survival even upon mTOR suppression74–77.